Which has the lower trailing P/E, ABBV or NVO?

NVO has the lower trailing P/E: ABBV trades at 73.61 and NVO at 10.50. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or NVO?

Over the past five years, NVO grew revenue faster — ABBV at a 3.69% CAGR versus NVO at 19.76%.

Does ABBV or NVO pay a bigger dividend?

ABBV yields 2.66% and NVO yields 4.17% based on trailing dividends and the latest price.

Is ABBV or NVO more profitable?

NVO runs the higher net margin — ABBV at 9.81% versus NVO at 35.33%.

How have ABBV and NVO total returns compared?

Over the past 10 years, ABBV delivered 19.85% and NVO delivered 9.46% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Novo Nordisk A/S (NVO)

A side-by-side comparison of AbbVie Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$461.59B

$261.26HealthcareDelayed quote: Sep 15, 2026, 10:35 AM EDT

NVO

Novo Nordisk A/S

$189.15B

$42.60HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT

Total return — ABBV vs NVO

growth of $100 · dividends reinvested · last 10y

ABBV +512.1% (+19.9%/yr)NVO +136.4% (+9.0%/yr)ABBV compounded faster over this window

ABBV NVO

ABBV vs NVO: by the numbers

•ABBV is the larger company ($461.59B vs $189.15B market cap).
•NVO trades at the lower trailing earnings multiple (10.50 vs 73.61 P/E), one valuation lens rather than an overall verdict.
•NVO converts more revenue to profit (35.33% vs 9.81% net margin).
•NVO grew revenue faster over the past five years (19.76% vs 3.69% CAGR).
•NVO pays the higher dividend yield (4.17% vs 2.66%).

Metrics side by side

Valuation

Metric	ABBV	NVO
P/E ratio	73.61	10.50
Forward P/E	18.60	N/A
P/S ratio	7.17	3.70
P/B ratio	N/A	5.61
EV / EBITDA	19.62	7.77
FCF yield	3.93%	3.94%

Profitability

Metric	ABBV	NVO
Gross margin	71.48%	80.64%
Operating margin	29.32%	43.10%
Net margin	9.81%	35.33%
ROE	N/A	53.50%
ROIC	13.46%	30.21%

Dividends

Metric	ABBV	NVO
Dividend yield	2.66%	4.17%
Payout ratio	192.43%	44.27%

Growth (annualized)

Metric	ABBV	NVO
Revenue CAGR (5Y)	3.69%	19.76%
EPS CAGR (5Y)	-2.79%	19.59%
FCF CAGR (5Y)	0.11%	-1.45%
Total return CAGR (5Y)	23.70%	-0.65%

Frequently asked

Which has the lower trailing P/E, ABBV or NVO?: NVO has the lower trailing P/E: ABBV trades at 73.61 and NVO at 10.50. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or NVO?: Over the past five years, NVO grew revenue faster — ABBV at a 3.69% CAGR versus NVO at 19.76%.
Does ABBV or NVO pay a bigger dividend?: ABBV yields 2.66% and NVO yields 4.17% based on trailing dividends and the latest price.
Is ABBV or NVO more profitable?: NVO runs the higher net margin — ABBV at 9.81% versus NVO at 35.33%.
How have ABBV and NVO total returns compared?: Over the past 10 years, ABBV delivered 19.85% and NVO delivered 9.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full NVO analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Novo Nordisk A/S P/E ratio AbbVie dividend yield Novo Nordisk A/S dividend yield AbbVie ROE Novo Nordisk A/S ROE AbbVie operating margin Novo Nordisk A/S operating margin AbbVie revenue growth Novo Nordisk A/S revenue growth AbbVie free cash flow Novo Nordisk A/S free cash flow

AbbVie & Novo Nordisk A/S appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.